Search Result "glimepiride DPP-4 inhibitors"
Inhibition of Dipeptidyl Peptidase-4 (DPP-4): A Target to Treat Type 2 Diabetes
Journal: Current Enzyme Inhibition
Volume: 7 Issue: 4 Year: 2011 Page: 205-217
Author(s): Bo Ahren
GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 5 Issue: 6 Year: 2005 Page: 485-497
Author(s): Juris J. Meier, Michael A. Nauck
Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Journal: Current Drug Safety
Volume: 6 Issue: 5 Year: 2011 Page: 304-309
Author(s): Nasser Mikhail
Study on Gluco-Regulatory Potential of Glimepiride Sulfonamide Using In silico, In Vitro and In Vivo Approaches
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 32 Year: 2014 Page: 5212-5217
Author(s): Hamendra Singh Parmar,Mahesh Kumar Bhinchar,Muskan Bhatia,Nikita Chordia,Ishan Raval,Digvijay Singh Chauhan,E. Manivannan,Rameshwar Jatwa,Anil Kumar
Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 34 Year: 2020 Page: 4315-4322
Author(s): Syed Wasif Gillani,Arzu F. Moosvi
A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 81-88
Author(s): Ryuichi Morishita, Sho-ichi Yamagishi
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 411-420
Author(s): Munehisa Bekki,Nobuhiro Tahara,Atsuko Tahara,Sachiyo Igata,Akihiro Honda,Yoichi Sugiyama,Tomohisa Nakamura,Jiahui Sun,Yuki Kumashiro,Takanori Matsui,Yoshihiro Fukumoto,Sho-ichi Yamagishi
Linagliptin: A Novel Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor for Treatment of Type II Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 7 Issue: 5 Year: 2011 Page: 325-335
Author(s): Somsuvra B. Ghatak, Devang S. Patel, Neeraj Shanker, Ambrish Srivastava, Shrikalp S. Deshpande, Shital J. Panchal
Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 13 Issue: 3 Year: 2013 Page: 256-263
Author(s): Ilker Tasci, Mehmet Ilkin Naharci, Ergun Bozoglu, Umut Safer, Aydogan Aydogdu, Basak Filiz Yilmaz, Gulay Yilmaz, Huseyin Doruk
Appraisal of Saxagliptin as Treatment of Type 2 Diabetes
Journal: Current Drug Therapy
Volume: 5 Issue: 2 Year: 2010 Page: 111-117
Author(s): Nasser Mikhail, Dennis Cope